| Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models |
|
|
|
|
|
|
|
|
|
| Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk |
|
|
|
|
|
|
|
|
|
| Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival |
|
|
|
|
|
|
|
|
|
| Delivering cancer genetics services-new ways of working |
|
|
|
|
|
|
|
|
|
| The extracolonic cancer spectrum in females with the common ‘South African’ hMLH1 c.C1528T mutation |
|
|
|
|
|
|
|
|
|
| Hereditary diffuse gastric cancer: association with lobular breast cancer |
|
|
|
|
|
|
|
|
|
| Gonadal mosaicism and familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers |
|
|
|
|
|
|
|
|
|
| Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management |
|
|
|
|
|
|
|
|
|
| Pancreatic cancer and the FAMMM syndrome |
|
|
|
|
|
|
|
|
|
| A hereditary cancer syndrome seminar: perspective of a Continuing Medical Education (CME) Director |
|
|
|
|
|
|
|
|
|
| Foreword |
|
|
|
|
|
|
|
|
|
| Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist |
|
|
|
|
|
|
|
|
|
| Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) |
|
|
|
|
|
|
|
|
|
| Is MSH2 a breast cancer susceptibility gene? |
|
|
|
|
|
|
|
|
|
| Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families |
|
|
|
|
|
|
|
|
|
| Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin |
|
|
|
|
|
|
✓ |
|
Indian (Gujarati) origin |
| Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma |
|
|
|
|
|
|
|
|
|
| Standards of care in diagnosis and testing for hereditary colon cancer |
|
|
|
|
|
|
|
|
|
| Chemoprevention with special reference to inherited colorectal cancer |
|
|
|
|
|
|
|
|
|
| A novel MSH2 germline mutation in a Druze HNPCC family |
|
|
|
|
|
|
✓ |
|
Druze |
| Hereditary neoplasia syndromes and the role of the surgeon |
|
|
|
|
|
|
|
|
|
| Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family |
|
|
|
|
|
|
|
|
|
| BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma |
|
|
|
|
|
|
|
|
|
| A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families |
|
|
|
|
|
|
✓ |
|
French Canadian |
| Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis |
|
|
|
|
|
|
|
|
|
| Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models |
|
|
|
|
|
|
|
|
|
| Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families |
|
|
|
|
|
|
✓ |
|
French Canadian |
| The 2nd Biennial Scientific Meeting of International Society for Gastrointestinal Hereditary Tumours |
|
|
|
|
|
|
|
|
|
| The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside |
|
|
|
|
|
|
|
|
|
| Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics |
|
|
|
|
|
|
|
|
|
| BRCA1/2 mutation analysis in male breast cancer families from North West England |
|
|
|
|
|
|
|
|
|
| Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes |
|
|
|
|
|
|
|
|
|
| Roles and responsibilities of a medical geneticist |
|
|
|
|
|
|
|
|
|
| Pathology of the hereditary colorectal carcinoma |
|
|
|
|
|
|
|
|
|
| Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types |
|
|
|
|
|
|
|
|
|
| Sharing experiences of user involvement in shaping new services: the story of a national patient group |
|
|
|
|
|
|
|
|
|
| Competences, education and support for new roles in cancer genetics services: outcomes from the cancer genetics pilot projects |
|
|
|
|
|
|
|
|
|
| The role of patient users in cancer genetics services in primary care |
|
|
|
|
|
|
|
|
|
| Improving access to cancer genetics services in primary care: socio-economic data from North Kirklees |
|
|
|
|
|
|
|
|
|
| Cancer genetics in rural primary care: a pilot nurse-led service using a new mobile IT system |
|
|
|
|
|
|
|
|
|
| Foreword |
|
|
|
|
|
|
|
|
|
| Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer |
|
|
|
|
|
|
|
|
|
| National evaluation of NHS genetics service investments: emerging issues from the cancer genetics pilots |
|
|
|
|
|
|
|
|
|
| Providing a community-based cancer risk assessment service for a socially and ethnically diverse population |
|
|
|
|
|
|
|
|
|
| Patient perspectives on the Poole PCT cancer genetics service |
|
|
|
|
|
|
|
|
|
| Open letter |
|
|
|
|
|
|
|
|
|
| Information recovery in cancer families: value for risk estimations |
|
|
|
|
|
|
|
|
|
| Delivering cancer genetics services-new ways of working |
|
|
|
|
|
|
|
|
|
| Delivery of cancer genetics services: The Royal Marsden telephone clinic model |
|
|
|
|
|
|
|
|
|
| Nurse-led cancer genetics clinics in primary and secondary care in varied ethnic population areas: interaction with primary care to improve ascertainment of individuals from ethnic minorities |
|
|
|
|
|
|
|
|
|
| The Teesside Cancer Family History Service: change management and innovation at cancer network level |
|
|
|
|
|
|
|
|
|
| Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families |
|
|
|
|
|
|
|
|
|
| Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer |
|
|
|
|
|
|
|
|
|
| Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study |
|
|
|
|
|
|
|
|
|
| Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study |
|
|
|
|
|
|
|
|
|
| Disseminating risk information to familial adenomatous polyposis families |
|
|
|
|
|
|
|
|
|
| Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia |
|
|
|
|
|
|
|
|
|
| Two TP53 germline mutations in a classical Li-Fraumeni syndrome family |
|
|
|
|
|
|
|
|
|
| An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation |
|
|
|
|
|
|
|
|
|
| Recurrent idiopathic pancreatitis in familial adenomatous polyposis: Report of a case-series and review of the literature |
|
|
|
|
|
|
|
|
|
| Patient preferences regarding recontact by cancer genetics clinicians |
|
|
|
|
|
|
|
|
|
| Utility of computed tomographic colonography in surveillance for hereditary nonpolyposis colorectal cancer syndrome |
|
|
|
|
|
|
|
|
|
| Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data |
|
|
|
|
|
|
|
|
|
| Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing |
|
|
|
|
|
|
|
|
|
| Identification of a founder BRCA2 mutation in Sardinian breast cancer families |
|
|
|
|
|
|
|
|
|
| The interval between cancer diagnosis among mothers and offspring in a population-based cohort |
|
|
|
|
|
|
|
|
|